hsCRP useful biomarker for early diagnosis of prediabetes: Study
Wardha, IND: A recent study has reported high sensitivity C-reactive protein (hsCRP) to be a definite predictor of inflammation in prediabetes. Also, hsCRP was found to be directly proportional to low-density lipoprotein and cholesterol -- risk factors of prediabetes.
Based on the findings, published in the journal Cureus, the authors concluded that hsCRP can be used as an early predictor of inflammation in prediabetes. It can also be a marker of underlying deranged sugar levels and lipid profile in pre-diabetics unaware of their health status.
Prediabetes is a state of intermediate hyperglycemia and is known to be associated with low-grade inflammation, although it looks benign. hs-CRP is a sensitive marker to detect low-grade inflammation. Sunil Kumar, Datta Meghe Institute of Medical Sciences (Deemed to be University), Wardha, IND, and colleagues aimed to study whether hsCRP can be used as a biomarker in the early diagnosis of pre-diabetes in a rural population.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.